Search Results
New data from the PACIFIC trial for NSCLC
Durvalumab Consolidation in NSCLC: The PACIFIC Trial
Locally Advanced NSCLC: Approaching the PACIFIC Trial
Examining Recent PACIFIC Trial Updates for Durvalumab in Locally Advanced NSCLC
Enhancing Benefit With Durvalumab in NSCLC After the PACIFIC Trial
Dr. Langer on Practice-Changing PACIFIC Data in Stage III NSCLC
The PACIFIC Trial: New Role for Immunotherapy in Locally Advanced NSCLC (BMIC-001)
PACIFIC Trial: Durvalumab Following Chemotherapy for Stage III NSCLC
Updated Results on PACIFIC Trial: Revise Who Should Receive Consolidation Immunotherapy? (BMIC-065)
Locally advanced NSCLC: Combination therapy with targeted and immunotherapy agents
CheckMate 816: what does the data tell us?
PACIFIC 6: durvalumab after sCRT in patients with NSCLC
